A hedge fund recently bought a new stake in Mustang Bio stock. Anson Funds Management LP bought a new stake in Mustang Bio, Inc. ( NASDAQ:MBIO – Free Report ) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 45,716 shares of the company's stock, valued at approximately $57,000. Anson Funds Management LP owned 1.04% of Mustang Bio as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 9.95% of the company's stock.